Literature DB >> 7685977

Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.

J Bujía1, V Schilling, A Holly, M Stammberger, E Kastenbauer.   

Abstract

Cholesteatoma is characterized by the presence of a squamous epithelium invading the middle ear altering its growth properties. This epithelium is believed to have hyperproliferative properties. Keratin 16 is accepted as a molecular marker for hyperproliferative epithelia. Two monoclonal antibodies K8.12 (directed against keratin 13) and KS.1A3 (directed against keratin 13 and 16) were used in an alkaline phosphatase anti-alkaline-phosphatase (APAAP)-technique to compare the expression of both keratin 13 and keratin 16 in normal human skin and aural cholesteatoma. Furthermore, the cytokeratin expression was compared to that of normal skin and palatine tonsil using one-dimensional gel electrophoresis. For both monoclonal antibodies, normal ear skin was stained only in the basal layer. In contrast, in the cholesteatoma samples the immunostaining of the antibody KS-1A3 was done not only in the basal cell layer but also in the suprabasal cells of the stratum spinosum and stratum granulosum. Using gel-electrophoresis, the presence of cytokeratin 16 was demonstrated in the cholesteatoma samples only. These results support the hyperproliferative character of cholesteatoma epithelium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685977     DOI: 10.3109/00016489309135826

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  15 in total

1.  Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.

Authors:  J Bujia; H Sudhoff; A Holly; H Hildmann; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.

Authors:  J Bujía; C Kim; P Ostos; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

3.  Inexpensive computer analysis of cell and tissue stainings.

Authors:  M Sittinger; J Bujia; G R Burmester
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-09       Impact factor: 2.416

4.  Optical imaging with a high-resolution microendoscope to identify cholesteatoma of the middle ear.

Authors:  Lauren L Levy; Nancy Jiang; Eric Smouha; Rebecca Richards-Kortum; Andrew G Sikora
Journal:  Laryngoscope       Date:  2013-01-08       Impact factor: 3.325

5.  Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.

Authors:  A Holly; M Sittinger; J Bujia
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

6.  Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.

Authors:  Ewa Olszewska; Jürgen Lautermann; Can Koc; Matthias Schwaab; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-08       Impact factor: 2.503

Review 7.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

8.  Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion.

Authors:  Salvatore Raffa; Laura Leone; Cristina Scrofani; Simonetta Monini; Maria Rosaria Torrisi; Maurizio Barbara
Journal:  Histochem Cell Biol       Date:  2012-04-06       Impact factor: 4.304

9.  Evaluation of bcl-2, bax and c-erbB-2 Levels in Chronic Otitis Patients with or without Cholesteatoma.

Authors:  Özgür Işık; Turgut Karlıdağ; Bengü Çobanoğlu Şimşek; Erol Keleş; İrfan Kaygusuz; Şinasi Yalçın; İsrafil Orhan; Emrah Sapmaz
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-06-01

10.  Comparative analysis of the expression of involucrin, filaggrin and cytokeratin 4, 10, 16 in cholesteatoma.

Authors:  Hyun Jung Min; Chul Won Park; Jin Hyeok Jeong; Seok Hyun Cho; Kyung Rae Kim; Seung Hwan Lee
Journal:  Korean J Audiol       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.